News & Updates
Filter by Specialty:
Elagolix on par with dienogest for endometriosis-related pain
In the treatment of pain due to endometriosis, use of elagolix 150-mg tablets demonstrates comparable efficacy to dienogest 2-mg tablets, as assessed via numeric rating scale (NRS) score from baseline to day 85 and 169, according to a study presented at RCOG 2024. Additionally, both drugs are well tolerated.
Elagolix on par with dienogest for endometriosis-related pain
11 Nov 2024
Oral misoprostol solution measures up to tablet formulation for labour induction
The off-label oral solution of misoprostol proves noninferior to the licensed oral tablet for induction of labour, with no significant difference in the occurrence of vaginal delivery within 24 hours, according to a study.
Oral misoprostol solution measures up to tablet formulation for labour induction
08 Nov 2024
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
08 Nov 2024
Menopausal hormone therapy prevents relapse in women with SSD
Use of menopausal hormone therapy (MHT) can avert psychosis relapse in women with schizophrenia or schizoaffective disorder (SSD) of menopausal age, suggests a recent study.
